Events

Avis De Sécurité sur ARCHITECT Anti-HBc II

Selon Ministry of Health, State Institute for Drug Control, Coordination Center for Departmental Medical Information Systems, ce/cet/cette avis de sécurité concerne un dispositif en/au/aux/à Czechia qui a été fabriqué par ABBOTT.

Qu'est-ce que c'est?

Les avis de sécurité sont des communications que les fabricants de dispositifs médicaux ou leurs représentants font parvenir en particulier aux travailleurs du secteur médical, mais aussi aux utilisateurs de ces dispositifs. Les avis de sécurité concernent les actions entreprises quant aux dispositifs présents sur le marché et peuvent inclure des rappels et des alertes.

En savoir plus sur les données ici
  • Type d'événement
    Field Safety Notice
  • ID de l'événement
    157
  • Date
    2015-09-01
  • Pays de l'événement
    Czechia
  • Source de l'événement
    MHSIDCCCDMIS
  • URL de la source de l'événement
    https://eregpublicsecure.ksrzis.cz/Registr/RZPRO/FSN
  • Notes / Alertes
    Czech data is current through July 2018. All of the data comes from the Czech Public Registry of Medical Devices, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and the Czech Republic.
  • Notes supplémentaires dans les données

Device

ARCHITECT Anti-HBc II
  • Modèle / numéro de série
    Catalog Number: 8L44-25, 8L44-30, 8L44-35 Batch Number: 42072LI00 42072LI01 42253LI00 42253LI01 42255LI00 42255LI01 42256LI00
  • Description du dispositif
    Diagnostic medical devices in vitro
  • Manufacturer
    ABBOTT

Manufacturer

ABBOTT
  • Société-mère du fabricant (2017)
    Abbott Laboratories
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    MHSIDCCCDMIS